Nattokinase Dose Per Day: Evidence-Based Guide

Nattokinase capsules arranged in three dosage groups on marble surface showing different daily dose options

In This Article

Key Takeaways

  • Sebuah meta-analisis dari enam uji coba terkontrol secara acak (546 peserta) menemukan bahwa 2.000 FU per hari secara signifikan mengurangi tekanan darah sistolik rata-rata sebesar 3,45 mmHg
  • Studi klinis terbesar (1.062 peserta, 12 bulan) menggunakan 10.800 FU setiap hari dan menemukan pengurangan signifikan pada plak arteri — namun ini adalah studi observasional, bukan uji coba acak.
  • FU (Unit Fibrinolitik) mengukur aktivitas enzim, bukan berat — dua produk nattokinase "100 mg" dapat memiliki potensi yang sangat berbeda jika FU tidak disebutkan
  • Asosiasi Nattokinase Jepang (JNKA) merekomendasikan dosis standar 2.000 FU per hari dan mengharuskan pelabelan berbasis FU pada produk yang tersertifikasi
  • Data keamanan mendukung dosis hingga 10.800 FU per hari selama 12 bulan tanpa efek samping, meskipun dosis di atas 2.000 FU belum diuji dalam uji coba terkontrol secara acak.
  • Nattokinase tidak boleh dikonsumsi bersamaan dengan obat antikoagulan (warfarin, heparin) tanpa pengawasan medis karena risiko perdarahan yang meningkat.

You have a bottle of nattokinase in your hand — or you are about to buy one — and you want a simple answer: how much should you take each day? The problem is that the numbers you find online range from 2,000 FU to 10,800 FU, a fivefold difference that makes it nearly impossible to feel confident about your dose.

The confusion is understandable. Most supplement labels recommend 2,000 FU, but a widely cited clinical study used 10,800 FU and showed impressive cardiovascular results. Some sources call 2,000 FU "the standard," while others argue it falls short. Which is it?

The answer depends on what you are trying to achieve. A meta-analysis of six randomized controlled trials confirms that 2,000 FU per day reliably reduces blood pressure. A larger (but observational) study of over a thousand participants found that 10,800 FU per day reduced arterial plaque over twelve months. Different nattokinase doses per day serve different purposes — and the clinical evidence behind each dose varies in strength.

In this guide, we reviewed the published clinical research, compared findings from both international and Japanese studies, and mapped out which nattokinase dose per day matches which health goal — so you can make a decision grounded in evidence, not marketing.

Understanding Nattokinase Dosage Units

What Are Fibrinolytic Units (FU)?

Fibrinolytic Units measure nattokinase's actual biological activity — specifically, its ability to break down fibrin, the protein that forms blood clots. Unlike milligrams, which measure weight, FU tells you how potent the enzyme actually is [20].

The approximate conversion is 2,000 FU per 100 mg of nattokinase, but this ratio varies by manufacturer. A product labeled "100 mg nattokinase" without an FU specification tells you nothing about potency, because extraction and purification methods differ across producers.

FU vs Milligrams: Why It Matters

This distinction has real consequences for dosing. Consider two products:

Product Weight per Capsule FU per Capsule Actual Potency
Product A 100 mg 2,000 FU Standard
Product B 100 mg Not specified Unknown
Product C 200 mg 4,000 FU Double standard

If a supplement label only lists milligrams without FU, you cannot determine its potency. The Japan Nattokinase Association (JNKA) mandates FU-based labeling for certified products — a quality signal worth looking for [20]. All nattokinase products in our curated selection specify FU per serving.

When clinical studies report nattokinase doses, they use FU as the primary metric. Every dosage recommendation in this guide is expressed in FU for this reason.

Standard Nattokinase Dose: What Clinical Studies Used

The most widely studied nattokinase dose is 2,000 FU (approximately 100 mg) per day. This is the dose with the broadest evidence base and the longest safety track record.

The 2,000 FU Evidence Base

A systematic review and meta-analysis of six randomized controlled trials encompassing 546 participants found that nattokinase supplementation at doses ranging from 1,200 to 8,000 FU per day significantly reduced systolic blood pressure by an average of 3.45 mmHg, with the strongest effects in 8-week trials [1].

A randomized, double-blind, placebo-controlled, multicenter North American trial (79 participants) found that 2,000 FU daily for 8 weeks reduced diastolic blood pressure from approximately 87 to 84 mmHg and reduced von Willebrand factor, a cardiovascular risk marker [4].

An earlier study of 12 Japanese adults demonstrated that 2,000 FU daily for 2 months significantly decreased plasma fibrinogen (by 7.6%), factor VII (by 14%), and factor VIII (by 17.4%) — confirming fibrinolytic and anticoagulant effects at the standard dose [9].

An Important Caveat at Standard Doses

Not all outcomes respond to 2,000 FU. The NAPS (Nattokinase Atherothrombotic Prevention Study), a 3-year randomized controlled trial of 265 participants, found no significant effect on subclinical atherosclerosis progression at 2,000 FU daily. The authors acknowledged the dose may have been insufficient for this specific outcome [3].

This is an honest and important finding: 2,000 FU appears effective for blood pressure and fibrinolytic activity, but it may not be enough for arterial plaque management. That question leads to the higher-dose research below.

Nattokinase Dosage by Health Goal

Based on available clinical evidence, the right nattokinase dose per day depends on your specific health goal. The table below summarizes what the research supports:

Health Goal Evidence-Based Dose Study Support Evidence Level
Blood pressure support 2,000 FU/day Meta-analysis of 6 RCTs (n=546) [1] Strong
Fibrinolytic activity (clot prevention) 2,000 FU/day Multiple clinical studies [9] Strong
Cholesterol and lipid support 4,000 FU/day Post-stroke study (12 months) [2] Moderate
Cardiovascular/plaque management 10,800 FU/day Observational study (n=1,062) [2] Moderate (observational only)
General wellness and prevention 2,000 FU/day JNKA recommendation; most widely studied [20] Moderate

Choosing a nattokinase supplement? All three products in our curated selection are Japanese-manufactured with FU potency clearly labeled — including a 4,000 FU option for those targeting above-standard doses.

Blood Pressure Support: Strong Evidence

For blood pressure reduction, the evidence at 2,000 FU is the strongest in the entire nattokinase literature. The meta-analysis found a consistent systolic reduction of approximately 3.45 mmHg across multiple trials, with no notable adverse events reported [1].

If your primary goal is blood pressure support, 2,000 FU daily is the evidence-backed starting point.

Cholesterol and Lipid Support: Moderate Evidence

A study of post-stroke and transient ischemic attack patients found that 4,000 FU daily for 12 months reduced LDL cholesterol (p=0.02), though vascular event differences were not statistically significant [2]. This is the dose delivered by Japanese Nattokinase 4000, one of the products in our curated selection.

A separate randomized, double-blind, placebo-controlled trial found that nattokinase combined with red yeast rice showed synergistic effects on lipid profiles in patients with stable coronary artery disease, with no adverse events [5].

Cardiovascular and Arterial Health: The Higher-Dose Question

For arterial plaque management, the evidence points to higher doses — but with a critical caveat about study design. The next section covers this in detail.

Higher-Dose Research: The 10,800 FU Study

The largest clinical study of nattokinase to date enrolled 1,062 participants with atherosclerosis and hyperlipidemia and administered 10,800 FU daily for 12 months. Results showed significant reductions in carotid intima-media thickness, plaque size, and improvements in lipid profiles compared to a smaller comparison group receiving 3,600 FU daily. No adverse effects were reported [2].

These results are compelling, but context matters:

  • This was a retrospective observational study, not a randomized controlled trial. Participants were not randomly assigned to dose groups, and there was no placebo control. This limits the strength of causal conclusions.
  • The comparison group (3,600 FU) was smaller, making direct dose comparisons less reliable.
  • The study authors themselves called for randomized controlled trials to confirm these findings.
  • Participants were under physician supervision throughout the study period. This was not a self-directed supplementation protocol.

What this means for you: The 10,800 FU dose shows promise for cardiovascular and plaque management, but it has not been validated in the same rigorous way that 2,000 FU has been for blood pressure. If you are considering doses above 2,000 FU, discuss it with your healthcare provider. This is especially important because higher doses may amplify bleeding risk.

When and How to Take Nattokinase

Best Time of Day

No published clinical trial has directly compared morning versus evening nattokinase dosing. However, there is a physiological rationale worth considering.

The body's natural fibrinolytic (clot-dissolving) activity is lowest in the early morning hours — which is also when cardiovascular events like heart attacks and strokes are most likely to occur. Some practitioners suggest evening or bedtime dosing so that nattokinase activity peaks during this vulnerable window. This is a theoretical consideration, not a clinically proven strategy.

Most clinical trials administered nattokinase once daily without specifying time of day [1][4].

With or Without Food

Clinical trials did not consistently control for food timing. A pharmacokinetic pilot study confirmed that nattokinase is absorbed intact when taken orally and is detectable in serum, with peak activity several hours after ingestion [10]. Research in animal models indicates that nattokinase is absorbed through the small intestine via transcellular transport [11].

In the absence of definitive clinical guidance, follow the instructions on your product label.

Can You Split the Dose?

Most clinical trials used a single daily dose. There is no published evidence comparing split dosing (e.g., 1,000 FU morning + 1,000 FU evening) versus a single 2,000 FU dose. Unless your healthcare provider advises otherwise, taking your full daily dose at one time is consistent with how the research was conducted.

How Long Until You See Results

Nattokinase is not a fast-acting supplement. Based on clinical trial durations and measured endpoints, here is what the evidence shows:

Effect Time to Measurable Change Study Reference
Blood pressure reduction 4-8 weeks Meta-analysis subgroup analysis; Jensen et al. RCT [1]
Fibrinolytic activity (fibrinogen, factor VII/VIII) 8 weeks Hsia et al. [9]
Cholesterol and lipid changes 3-6 months Liu et al. RCT (12 weeks); post-stroke study (12 months) [5]
Arterial plaque changes ~12 months 10,800 FU observational study [2]
Circulation-related symptom relief ~30 days Gallelli et al. vascular patient study [6]

These timelines are based on when studies measured outcomes, not necessarily when effects begin. Individual responses will vary. Plan for at least 8 weeks of consistent daily use before evaluating whether nattokinase is working for your specific goal.

Safety Considerations

Overall Safety Profile

Nattokinase is generally well-tolerated. A systematic review of randomized controlled trials reported "no notable adverse events" across all included studies [1]. A real-world observational study of vascular disease patients confirmed no adverse events, with participant compliance exceeding 95% [6].

Toxicological assessment established a 90-day oral no-observed-adverse-effect level (NOAEL) in animal models at 1,000 mg/kg/day — orders of magnitude above human supplement doses [12].

Drug Interactions

This is the most critical safety consideration for nattokinase:

Medication Class Interaction Risk Level Action
Anticoagulants (warfarin, heparin, enoxaparin) Nattokinase enhances fibrinolytic effects, potentially increasing bleeding risk High Do not combine without medical supervision. INR monitoring essential [13]
Antiplatelet drugs (aspirin, clopidogrel) Additive anti-clotting action may increase bleeding risk Moderate-High Avoid without medical supervision [14]
Antihypertensives Additive blood pressure lowering Low-Moderate Monitor blood pressure; dose adjustments may be needed [4]

Who Should Avoid Nattokinase

  • People with bleeding disorders or elevated bleeding risk [13]
  • People taking anticoagulant or antiplatelet medications without medical oversight
  • Before surgery: Discontinue at least 1-2 weeks before surgical or dental procedures [13]
  • Pregnancy and nursing: Insufficient human safety data — not recommended [14]
  • Soy allergy: Nattokinase is derived from soy fermentation

Maximum Safe Dose

No serious adverse effects have been reported at doses up to 10,800 FU per day for 12 months (in a study of 1,062 participants) [2]. Separately, doses of 2,000-7,000 FU daily have been used for up to 3 years without significant adverse events. Toxicological studies show a large safety margin [12].

However, safety at higher doses has only been demonstrated in observational settings, not in randomized controlled trials. The precautionary principle applies: the higher the dose, the more important medical supervision becomes — particularly regarding bleeding risk.

Realistic Expectations

Nattokinase is not a replacement for prescribed cardiovascular medications. It should be considered a complementary supplement, not a substitute for medical treatment. If you are managing a cardiovascular condition, work with your healthcare provider to determine whether and how nattokinase fits into your overall plan.

The Science Behind Japanese Nattokinase Standards

Nattokinase was discovered by Dr. Hiroyuki Sumi while researching thrombolytic agents at Chicago University. His foundational research, continued at Okayama Prefectural University, confirmed the fibrin-dissolving properties of the enzyme extracted from natto — the traditional Japanese fermented soybean food that has been part of the Japanese diet for centuries [18]. Japan has the deepest research history with this enzyme, starting decades before international interest emerged.

JNKA Certification: A Quality Signal Worth Knowing

The Japan Nattokinase Association (JNKA, 日本ナットウキナーゼ協会) has over 30 member companies and sets quality standards for nattokinase products. JNKA-certified products must meet specific criteria: FU-based potency labeling (not just milligram weight), standardized fibrinolytic activity testing, and typical certification at 2,000-5,000 FU per dose [20].

Why this matters: In markets without JNKA-equivalent oversight, nattokinase potency is self-reported by manufacturers. JNKA certification provides independent verification that the FU count on the label reflects actual enzyme activity.

The NSK-SD Innovation: Vitamin K2 Removal

Standard natto-derived nattokinase naturally contains vitamin K2, which can interfere with warfarin therapy. Japan Bio Science Laboratory (日本生物科学研究所) developed NSK-SD, a nattokinase formulation with vitamin K2 specifically removed. This addresses one of the primary drug interaction concerns and is designed for people who need to avoid vitamin K — a uniquely Japanese safety innovation [20].

Why this matters: If you take blood thinners and are considering nattokinase (with your doctor's guidance), a vitamin K2-removed formulation like NSK-SD eliminates one variable from an already complex interaction picture.

Functional Food Regulatory Framework

Several Japanese nattokinase products hold 機能性表示食品 (Foods with Function Claims) certification from Japan's Consumer Affairs Agency (消費者庁), permitting evidence-based health claims like "supports healthy blood flow." This regulatory framework requires manufacturers to submit scientific evidence for review — a more structured approach than the dietary supplement framework in many international markets [21].

Why this matters: Japanese functional food certification provides an additional layer of evidence review that goes beyond basic manufacturing quality. It signals that the health claim on the label has been evaluated against published research.

Japanese Research Context in Global Perspective

A review of functional foods with antihypertensive effects published on J-STAGE examined nattokinase alongside other Japanese functional food ingredients, noting its validated blood-pressure-lowering mechanism [19]. This kind of research — situating nattokinase within Japan's broader functional food ecosystem — provides context that international studies focused on isolated clinical endpoints do not.

Our Recommendations

Japanese Nattokinase 4000

Why We Selected This: Delivers 4,000 FU per serving — the same dose shown in clinical research to reduce LDL cholesterol over 12 months. Double the standard 2,000 FU without needing multiple capsules. Manufactured in Japan with quality standards aligned to Japanese nattokinase production heritage.

View Japanese Nattokinase 4000 →

View Japanese Nattokinase 4000 →

Nattokinase EX

Why We Selected This: A cardiovascular-focused formulation designed for comprehensive heart and circulation support. From a Japanese manufacturer with specific expertise in nattokinase production. Selected for users who want nattokinase as part of a broader cardiovascular wellness approach.

View Nattokinase EX →

View Nattokinase EX →

Noguchi Nattokinase HQ

Why We Selected This: A premium formulation from the established Noguchi brand. Japanese-manufactured with attention to potency standardization. Selected for users who prioritize brand heritage and manufacturing quality in their supplement choices.

View Noguchi Nattokinase HQ →

View Noguchi Nattokinase HQ →

Product FU per Serving Best For Format
Japanese Nattokinase 4000 4,000 FU Users wanting above-standard dosing Capsules
Nattokinase EX Standard Cardiovascular-focused support Capsules
Noguchi Nattokinase HQ Standard Premium quality, brand heritage Capsules

Conclusion

The right nattokinase dose per day is not a single number — it depends on your health goal and the level of evidence you are comfortable with. For blood pressure support and general cardiovascular wellness, 2,000 FU daily is the dose with the strongest clinical evidence, supported by multiple randomized controlled trials and endorsed by the Japan Nattokinase Association. For more targeted cardiovascular outcomes like plaque management, higher doses (up to 10,800 FU) show promise but rest on observational data and warrant medical supervision.

Three things matter most when choosing your dose: understanding that FU (not milligrams) is the meaningful unit, matching your dose to your specific goal, and being transparent with your healthcare provider — especially if you take medications that affect blood clotting.

Nattokinase is one of the better-studied cardiovascular supplements, with a safety profile that inspires reasonable confidence at standard doses. Start with the evidence, adjust with guidance, and give it time to work.

If you are ready to choose a supplement, our team has reviewed and selected three Japanese-manufactured nattokinase products — each with verified FU potency, from brands with established nattokinase expertise. View our nattokinase selection →

This article is for informational purposes only and does not constitute medical advice. Consult a healthcare professional before starting any new health regimen, especially if you have existing health conditions or take medications. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease.

Frequently Asked Questions

Dosis nattokinase yang paling banyak dipelajari dan direkomendasikan adalah 2.000 FU (sekitar 100 mg) per hari. Dosis ini didukung oleh meta-analisis dari enam uji coba terkontrol secara acak yang menunjukkan penurunan tekanan darah yang signifikan, dan merupakan dosis yang direkomendasikan oleh Japan Nattokinase Association (JNKA) untuk dukungan kesehatan umum. Dosis yang lebih tinggi (4.000-10.800 FU) telah digunakan dalam studi klinis untuk tujuan kardiovaskular tertentu, tetapi memerlukan pengawasan medis.
Untuk dukungan tekanan darah dan aktivitas fibrinolitik umum, 2.000 FU per hari didukung dengan baik oleh uji coba terkontrol secara acak. Namun, sebuah RCT selama 3 tahun menemukan bahwa 2.000 FU tidak cukup untuk memperlambat perkembangan aterosklerosis. Apakah 2.000 FU "cukup" tergantung pada tujuan kesehatan spesifik Anda — ini efektif untuk beberapa hasil tetapi mungkin tidak memadai untuk yang lain.
Studi klinis terbesar menggunakan 10.800 FU setiap hari selama 12 bulan pada 1.062 peserta tanpa efek samping yang dilaporkan. Namun, ini adalah studi observasional yang diawasi oleh dokter, bukan protokol yang dilakukan sendiri. Jika Anda mempertimbangkan dosis pada tingkat ini, konsultasikan dengan penyedia layanan kesehatan Anda — terutama jika Anda mengonsumsi obat apa pun yang memengaruhi pembekuan darah.
Dosis tertinggi yang diuji dalam studi yang dipublikasikan adalah 10.800 FU per hari selama 12 bulan, tanpa efek samping yang dilaporkan. Secara terpisah, dosis 2.000-7.000 FU telah didokumentasikan hingga 3 tahun. Studi toksikologi pada model hewan menunjukkan margin keamanan yang sangat besar. Tidak ada "maksimum" yang ditetapkan, tetapi dosis yang lebih tinggi membawa risiko perdarahan teoretis yang lebih besar dan harus diawasi.
Belum ada uji klinis yang secara langsung membandingkan dosis pagi versus malam. Ada alasan teoretis untuk dosis malam: aktivitas alami tubuh dalam melarutkan bekuan darah paling rendah pada jam-jam awal pagi, saat kejadian kardiovaskular paling sering terjadi. Mengonsumsi nattokinase sebelum tidur secara teori dapat meningkatkan aktivitas fibrinolitik selama periode rentan ini. Sebagian besar uji klinis memberikan dosis sekali sehari tanpa menentukan waktu pemberian.
Nattokinase telah terbukti secara mandiri menurunkan tekanan darah, jadi menggabungkannya dengan obat antihipertensi dapat menghasilkan efek tambahan. Ini tidak selalu berbahaya, tetapi berarti tekanan darah Anda bisa turun lebih rendah dari yang diharapkan. Pantau tekanan darah Anda dan beri tahu penyedia layanan kesehatan bahwa Anda mengonsumsi nattokinase bersamaan dengan obat resep.
Berdasarkan jadwal uji klinis, efek pada tekanan darah mulai dapat diukur dalam 4-8 minggu. Perubahan pada penanda fibrinolitik (fibrinogen, faktor VII, faktor VIII) terdeteksi pada 8 minggu. Perubahan kolesterol mungkin memerlukan 3-6 bulan, dan perubahan plak arteri diukur setelah 12 bulan penggunaan dosis tinggi. Rencanakan penggunaan harian yang konsisten minimal selama 8 minggu.
FU (Unit Fibrinolitik) mengukur aktivitas enzim nattokinase — seberapa efektif enzim tersebut melarutkan gumpalan fibrin. Miligram mengukur berat. Konversi kira-kira adalah 2.000 FU per 100 mg, tetapi ini bervariasi menurut produsen. FU adalah metrik yang bermakna secara klinis. Produk yang hanya mencantumkan miligram tanpa menyebutkan FU tidak memberikan informasi yang cukup untuk menilai potensi. Cari produk dengan FU yang tercantum jelas pada label.
Uji klinis tidak selalu mengontrol waktu konsumsi makanan secara konsisten, dan sebuah studi farmakokinetik mengonfirmasi bahwa nattokinase diserap secara utuh saat dikonsumsi secara oral. Tidak ada bukti klinis yang menunjukkan bahwa suplemen ini harus dikonsumsi bersama makanan. Ikuti petunjuk pada label produk Anda, dan jika Anda mengalami ketidaknyamanan pencernaan, coba konsumsi bersama makanan.
Studi terpanjang yang dipublikasikan menggunakan nattokinase adalah uji coba NAPS selama 3 tahun dengan dosis 2.000 FU per hari, yang melaporkan tidak ada kejadian merugikan yang signifikan. Data keamanan pada dosis lebih tinggi tersedia hingga 12 bulan. Untuk dosis standar, bukti saat ini mendukung keamanan jangka panjang, tetapi data lebih dari 3 tahun belum tersedia. Pemeriksaan berkala dengan penyedia layanan kesehatan Anda disarankan.
Ini adalah pertanyaan yang rumit. Nattokinase yang berasal dari natto standar secara alami mengandung beberapa vitamin K2. Jika Anda tidak menggunakan warfarin atau obat lain yang sensitif terhadap vitamin K, ini bukan masalah. Jika Anda menggunakan warfarin, carilah formulasi NSK-SD, yang secara khusus menghilangkan vitamin K2 untuk menghindari gangguan pada terapi antikoagulan. Mengonsumsi suplemen K2 bersamaan dengan nattokinase adalah keputusan terpisah — konsultasikan dengan penyedia layanan kesehatan Anda.
Kekhawatiran utama terkait konsumsi nattokinase berlebihan adalah peningkatan risiko pendarahan akibat aktivitas fibrinolitik yang meningkat. Meskipun studi toksikologi menunjukkan margin keamanan yang sangat besar — model hewan dapat mentolerir dosis yang jauh melebihi tingkat suplemen manusia tanpa bahaya — risiko praktis dari dosis berlebihan berkaitan dengan pendarahan, bukan toksisitas. Tanda-tanda yang perlu diperhatikan meliputi memar yang tidak biasa, pendarahan yang lama dari luka, atau darah dalam urine atau tinja. Segera cari bantuan medis jika hal ini terjadi.
  1. Suplemen Nattokinase dan faktor risiko kardiovaskular: tinjauan sistematis dan meta-analisis dari uji coba terkontrol secara acak
  2. Manajemen efektif perkembangan aterosklerosis dan hiperlipidemia dengan nattokinase
  3. Studi pencegahan aterotrombotik Nattokinase: Uji coba terkontrol secara acak
  4. Konsumsi nattokinase dikaitkan dengan penurunan tekanan darah dan faktor von Willebrand
  5. Efek kardiovaskular nattokinase yang dikombinasikan dengan beras ragi merah pada pasien dengan penyakit arteri koroner stabil
  6. Data yang dicatat dalam kehidupan nyata mendukung keamanan nattokinase pada pasien dengan penyakit pembuluh darah
  7. Kemajuan penelitian nattokinase dalam mengurangi lipid darah
  8. Efek suplemen Nattokinase-Monascus pada dislipidemia
  9. Nattokinase menurunkan kadar plasma fibrinogen, faktor VII, dan faktor VIII pada subjek manusia
  10. Sebuah studi awal tentang farmakokinetik serum nattokinase pada manusia
  11. Studi tentang mekanisme transportasi dan internalisasi suplemen makanan nattokinase di usus halus
  12. Penilaian toksikologi nattokinase yang berasal dari Bacillus subtilis var. natto
  13. Nattokinase: agen antitrombotik oral untuk pencegahan penyakit kardiovaskular
  14. Nattokinase: alternatif menjanjikan dalam pencegahan dan pengobatan penyakit kardiovaskular
  15. Nattokinase sebagai strategi terapi tambahan untuk penyakit tidak menular
  16. Natto dan bahan aktifnya nattokinase: Agen trombolitik yang kuat dan aman
  17. Menavigasi Efek Suplemen Anti-Aterosklerotik dan Mengakui Risiko Perdarahan yang Terkait
  18. Natto sebagai makanan fungsional: Enzim pelarut bekuan darah nattokinase dan efek pemberiannya
  19. Aksi farmakologis makanan fungsional yang memiliki efek penurunan tekanan darah

Continue Reading

Related Articles

gut brain connection

Gut-Brain Connection: Science, Supplements & Safety

April 27, 2026
memory support supplement

Memory Support Supplements: What Works

April 27, 2026
gut brain axis

Gut-Brain Axis: How Your Gut Affects Your Mind

April 26, 2026